Funds research to develop medical products for treating or curing ALS and other rare neurodegenerative diseases in adults and children.
Funds clinical trials for new treatments or labeling changes for rare neurodegenerative diseases in adults and children, aiming to increase FDA-approved therapies.
This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.
This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
CDC/ATSDR seeks research proposals to study and evaluate risk factors for ALS, including environmental, genetic, and population-specific factors, with funding for various research approaches and populations.